Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Muscarinic acetylcholine receptors: novel opportunities for drug development
Andrew C. Kruse, Brian K. Kobilka, Dinesh Gautam, et al.
Nature Reviews Drug Discovery (2014) Vol. 13, Iss. 7, pp. 549-560
Open Access | Times Cited: 389

Showing 1-25 of 389 citing articles:

A genetically encoded fluorescent acetylcholine indicator for in vitro and in vivo studies
Miao Jing, Peng Zhang, Guangfu Wang, et al.
Nature Biotechnology (2018) Vol. 36, Iss. 8, pp. 726-737
Open Access | Times Cited: 344
Crystal structures of the M1 and M4 muscarinic acetylcholine receptors
David M. Thal, Bingfa Sun, Dan Feng, et al.
Nature (2016) Vol. 531, Iss. 7594, pp. 335-340
Open Access | Times Cited: 326
Structure of the M2 muscarinic receptor–β-arrestin complex in a lipid nanodisc
Dean P. Staus, Hongli Hu, Michael J. Robertson, et al.
Nature (2020) Vol. 579, Iss. 7798, pp. 297-302
Open Access | Times Cited: 295
Allosteric Modulation as a Unifying Mechanism for Receptor Function and Regulation
Jean‐Pierre Changeux, Arthur Christopoulos
Cell (2016) Vol. 166, Iss. 5, pp. 1084-1102
Open Access | Times Cited: 285
Complex Pharmacology of Free Fatty Acid Receptors
Graeme Milligan, Bharat Shimpukade, Trond Ulven, et al.
Chemical Reviews (2016) Vol. 117, Iss. 1, pp. 67-110
Open Access | Times Cited: 247
Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders
Daniel J. Foster, P. Jeffrey Conn
Neuron (2017) Vol. 94, Iss. 3, pp. 431-446
Open Access | Times Cited: 218
Advances in G Protein-Coupled Receptor Allostery: From Function to Structure
Arthur Christopoulos
Molecular Pharmacology (2014) Vol. 86, Iss. 5, pp. 463-478
Open Access | Times Cited: 213
Gut Bacteria and Neurotransmitters
Leon M. T. Dicks
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1838-1838
Open Access | Times Cited: 205
The Biosynthesis, Signaling, and Neurological Functions of Bile Acids
Yoshimitsu Kiriyama, Hiromi Nochi
Biomolecules (2019) Vol. 9, Iss. 6, pp. 232-232
Open Access | Times Cited: 153
Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity
Otávio Cabral-Marques, Gilad Halpert, Lena F. Schimke, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 115
Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?
Flavio Ballante, Albert J. Kooistra, Stefanie Kampen, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1698-1736
Open Access | Times Cited: 104
Comparative studies of AlphaFold, RoseTTAFold and Modeller: a case study involving the use of G-protein-coupled receptors
Chien Lee, Bo‐Han Su, Yufeng Jane Tseng
Briefings in Bioinformatics (2022) Vol. 23, Iss. 5
Open Access | Times Cited: 79
Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia
Steven M. Paul, Samantha E. Yohn, Michael Popiolek, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 9, pp. 611-627
Closed Access | Times Cited: 78
Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications
Mallikarjuna Nimgampalle, Harshini Chakravarthy, Sapana Sharma, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101994-101994
Closed Access | Times Cited: 66
G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders
Thian‐Sze Wong, Guangzhi Li, Shiliang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 60
Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery
Paolo Conflitti, Edward Lyman, Mark S.P. Sansom, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 2
Activation of TRPV1 channels inhibits mechanosensitive Piezo channel activity by depleting membrane phosphoinositides
István Borbíró, Doreen Badheka, Tibor Rohács
Science Signaling (2015) Vol. 8, Iss. 363
Open Access | Times Cited: 174
The chemistry and biological activity of heterocycle-fused quinolinone derivatives: A review
Tomoya Shiro, Takayuki Fukaya, Masanori Tobe
European Journal of Medicinal Chemistry (2014) Vol. 97, pp. 397-408
Closed Access | Times Cited: 137
Mechanism of the G-protein mimetic nanobody binding to a muscarinic G-protein-coupled receptor
Yinglong Miao, J. Andrew McCammon
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 12, pp. 3036-3041
Open Access | Times Cited: 130
Cholinergic circuits in cognitive flexibility
Vânia F. Prado, Helena Janíčková, Mohammed Al‐Onaizi, et al.
Neuroscience (2016) Vol. 345, pp. 130-141
Closed Access | Times Cited: 124
New Binding Sites, New Opportunities for GPCR Drug Discovery
H. C. Stephen Chan, Yi Li, Thamani Dahoun, et al.
Trends in Biochemical Sciences (2019) Vol. 44, Iss. 4, pp. 312-330
Open Access | Times Cited: 123
Organophosphorus Nerve Agents: Types, Toxicity, and Treatments
Sudisha Mukherjee, Tarkeshwar Gupta
Journal of Toxicology (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 120
Muscarinic regulation of dopamine and glutamate transmission in the nucleus accumbens
Jung Hoon Shin, Martín F. Adrover, Jürgen Wess, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 26, pp. 8124-8129
Open Access | Times Cited: 110
GPCR crystal structures: Medicinal chemistry in the pocket
Jeremy Shonberg, Ralf C. Kling, Peter Gmeiner, et al.
Bioorganic & Medicinal Chemistry (2014) Vol. 23, Iss. 14, pp. 3880-3906
Closed Access | Times Cited: 104
Parkinsonism Driven by Antipsychotics Originates from Dopaminergic Control of Striatal Cholinergic Interneurons
Geetika Kharkwal, Karen Brami‐Cherrier, José Lizardi-Ortiz, et al.
Neuron (2016) Vol. 91, Iss. 1, pp. 67-78
Open Access | Times Cited: 102
Page 1 - Next Page

Scroll to top